πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8653243

Pertussis antibodies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653034

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8652366

Aerosol-mediated particle synthesis

The Board of Regents of the University of Texas System Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8648102

Compounds for treatment of cell proliferative diseases

The Board of Regents of the University of Texas System Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637503

Phenothiazine enantiomers as agents for the prevention of bone loss

The Board of Regents of the University of Texas System Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637675

Inhibitors of proliferation and activation of signal transducer and activators of transcri

The Board of Regents of the University of Texas System Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8632510

Nanochanneled device and related methods

The Board of Regents of the University of Texas System Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8629119

Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

The Board of Regents of the University of Texas System Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618074

GPCR enhanced neuroprotection to treat brain injury

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618324

Composition and method for making oligo-benzamide compounds

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618167

Methods of attenuating cognitive deficits with sulfonyl fluorides

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8617538

Mesodermal-like cell population for treating ischemia in mammals

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8613944

Compositions and methods for separating tissue

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8614082

Attenuation of encephalitogenic alphavirus and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8609067

Method of measuring propulsion in lymphatic structures

The Board of Regents of the University of Texas System Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8604074

Pro-neurogenic compounds

The Board of Regents of the University of Texas System Β· Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8597616

Dry powder drug delivery formulations, methods of use, and devices therefore

The Board of Regents of the University of Texas System Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8592384

Micro-RNA's that regulate muscle cells

The Board of Regents of the University of Texas System Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8586553

Therapies for cancer using RLIP76

The Board of Regents of the University of Texas System Β· Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8586046

Methods and compositions for mycoplasma pneumoniae exotoxins

The Board of Regents of the University of Texas System Β· Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8580845

Functionalized expanded porphyrins

The Board of Regents of the University of Texas System Β· Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8580738

Methods for treatment of reperfusion injury and other cardiac conditions

The Board of Regents of the University of Texas System Β· Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563595

Treatment of cancer with complex organic-inorganic pigment compositions

The Board of Regents of the University of Texas System Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563022

Particles for cell targeting

The Board of Regents of the University of Texas System Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted